Correlation Between Pasithea Therapeutics and Centessa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pasithea Therapeutics Corp and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Pasithea Therapeutics and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Centessa Pharmaceuticals.

Diversification Opportunities for Pasithea Therapeutics and Centessa Pharmaceuticals

-0.42

Correlation Coefficient

Pasithea Therapeutics  Centessa Pharmaceuticals

Very good diversification

The 3 months correlation between Pasithea and Centessa is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Centessa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Centessa Pharmaceuticals

Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Centessa Pharmaceuticals. In addition to that, Pasithea Therapeutics is 2.42 times more volatile than Centessa Pharmaceuticals PLC. It trades about -0.03 of its total potential returns per unit of risk. Centessa Pharmaceuticals PLC is currently generating about 0.08 per unit of volatility. If you would invest  1,463  in Centessa Pharmaceuticals PLC on September 4, 2024 and sell it today you would earn a total of  232.00  from holding Centessa Pharmaceuticals PLC or generate 15.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Pasithea Therapeutics Corp  vs.  Centessa Pharmaceuticals PLC

Pasithea Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Centessa Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pasithea Therapeutics and Centessa Pharmaceuticals

The main advantage of trading using opposite Pasithea Therapeutics and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.

The idea behind Pasithea Therapeutics Corp and Centessa Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.